Skip to main content
Caplight Logo









Silver Spur Therapeutics

Silver Spur Therapeutics

Private
Los Angeles, CaliforniaHealthcare & Life Scienceshttps://silverspurtx.com/

Last Round

Accelerator

Jun 17, 2025

Total Funding Raised

$440,000

Company Overview

Silver Spur Therapeutics is a biotechnology company that develops a proprietary nanomedicine delivery platform using peptide amphiphile micelles to target kidney and cardiovascular diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

nanotherapeutic deliverynanomedicinepeptide amphiphile micellesPAMsdrug delivery platformgene therapy deliveryrenal-targeted therapyRNA therapeuticsprecision medicinetargeted drug deliverybiotech startuppreclinical biotechADPKD treatmentdrug delivery techbiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Silver Spur Therapeutics Comparables

Compare Silver Spur Therapeutics with similar companies based on industry and business-model similarity.

Silver Spur Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Zeal Therapeutics, Inc.
86%
Nephrogen
81%
Judo Bio
77%

Silver Spur Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 17, 2025
AcceleratorJun 17, 2025
AcceleratorMar 10, 2025

Key People

Founding team and executive leadership

Yi HUANG

Chief Technology Officer

Executive Team

Silver Spur Therapeutics Investors

Notable investors and investment history

Silver Spur Therapeutics investors
InvestorRounds
TechstarsAccelerator
StoryHouse VenturesAccelerator
University of Southern CaliforniaAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2025

    $220K round led by Techstars

Silver Spur Therapeutics Filings

Explore SEC and related filing metadata, where available.

Silver Spur Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Silver Spur Therapeutics's valuation, stock price, and market status.

Is Silver Spur a public or private company?

Silver Spur is a private company.

What is the current stock price of Silver Spur?

Silver Spur is a private company with no public stock price. No recent secondary market data is available.

How much is Silver Spur worth (valuation)?

Valuation information for Silver Spur is not publicly available.

Can I buy Silver Spur stock?

Silver Spur shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Silver Spur's last funding round?

Silver Spur's most recent funding round was Accelerator on March 10, 2025.

Who are the main investors in Silver Spur?

Key investors in Silver Spur include Techstars.

Will Silver Spur IPO soon?

No public IPO plans have been announced for Silver Spur.

How can I track Silver Spur secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Silver Spur's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLos Angeles, California
Employee Range3
Year Founded2023
Last FundingJun 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?